Association of cutaneous and oral diseases in HIV-infected men

Oral Diseases

Volumn 4, Issue 1, 1998, Pages 16-21

  Mirowski, G W ^a,d   Hilton, J F ^b   Greenspan, D ^c   Canchola, A J ^c   MacPhail, L A ^c   Maurer, T ^b   Berger, T G ^b   Greenspan, J S ^c  

^a Indiana University   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d INDIANA UNIVERSITY   (United States)

Author keywords

HIV infections; Immunologic deficiency syndromes; Mucous membranes; Oral manifestations; Skin diseases

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DISEASE COURSE; FOLLICULITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOLLUSCUM CONTAGIOSUM; MOUTH DISEASE; MOUTH ULCER; PREDICTION; PRIORITY JOURNAL; SEBORRHEIC DERMATITIS; SKIN DISEASE; THRUSH; XEROSIS;

EID: 0031681390     PISSN: 1354523X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1601-0825.1998.tb00249.x     Document Type: Article

References (18)

1. Barone R, Ficarra G, Gaglioti D et al (1990). Prevalence of oral lesions among HIV-infected intravenous drug abusers and other risk groups. Oral Surg Oral Med Oral Pathol 69: 169-173.
2. Center for Disease Control and Prevention (1992). 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 41(RR-17): 1-19.
3. Coldiron BM, Bergstresser PR (1989). Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol 125: 357-361.
4. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases (1987). Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep 36 (Suppl 1): 1S-15S.
5. Farizo KM, Buehler JW, Chamberland ME et al (1992). Spectrum of disease in persons with human immunodeficiency virus infection in the United States. J Am Med Assoc 267: 1798-1805.
6. Feigal DW, Katz MH, Greenspan D et al (1991). The prevalence of oral lesions in HIV-infected homosexual and bisexual men: three San Francisco epidemiological cohorts. AIDS 5: 519-525.
7. Garbe C, Husak R, Orfanus CE (1994). HIV-associated dermatoses and their prevalence in 456 HIV-infected patients. Relation to immune status and its importance as a diagnostic marker. Hautarzt 45: 623-629.
8. Greenspan D. Greenspan JS, Hearst NG et al (1987). Relation of oral hairy leukoplakia to infection with the human immuno-deficiency virus and the risk of developing AIDS. J Infect Dis 155(3): 475-181.
9. Greenspan D, Greenspan JS, Overby G et al (1991). Risk factors for rapid progression from hairy Ieukoplakia to AIDS: a nested case-control study. J Acquir Immune Defic Syndr 4: 652-658.
10. Goodman DS, Teplitz ED, Wishner A et al (1987). Prevalence of cutaneous disease in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. J Am Acad Dermatol 17(2 Pt 1): 210-20.
11. Healy E, Meenan J, Mulcahy F et al (1993). The spectrum of HIV related skin diseases in an Irish population. Ir Med J 86(6): 188-190.
12. Hilton JF, Donegan E, Katz MH et al (1997). Development of oral lesions in human immunodeficiency virus-infected transfusion recipients and hemophiliacs. Am J Epidemtol 145: 164-174.
13. Katz MH, Greenspan D, Westenhouse J et al (1992). Progression to AIDS in HIV-infected homosexual and bisexual men with hairy leukoplakia and oral candidiasis. AIDS 6: 95-100.
14. Lamster IB, Begg MD, Mitchell-Lewis D et al (1994). Oral manifestations of HIV infection in homosexual men and intravenous drug users: study design and relationship of epidemiologic, clinical, and immunologic parameters to oral lesions. Oral Surg Oral Med Oral Pathol 78: 163-174.
15. Palacio H, Hilton JF, Canchola AJ et al (1997). Effect of cigarette smoking in HIV-related oral lesions. J Aquir Immune Defic Syndr Hum Retroviral 14: 338-342.
16. Peter RU, Richarz-Barthauer U (1995). Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicenter, double-blind, placebo-controlled trial. Br J Dermatol 132: 441-445.
17. Smith KJ, Skelton HG, Yeager J et al (1994). Cutaneous findings in HTV-1-positive patients: a 42-month prospective study. J Am Acad Dermatol 31: 746-754.
18. Stern RS (1994). Epidemiology of skin disease in HIV infection: a cohort study of health maintenance organization members. J Invest Dermatol 102: 34S-37S.